More than 23 million people in the U.S. suffer from rare and prevalent inflammatory diseases, including Still’s disease, idiopathic pulmonary disease –...
Epigenos Biosciences, Enfuego Therapeutics, Enzerna Biosciences, and NabGen Inc. receive funding to turn inventions created at UNC-Chapel Hill into transformative...
Alliance Between UNC-Chapel Hill and Deerfield intends to advance select Carolina innovations toward a possible new treatment against multiple myeloma...
Initos Pharmaceuticals and STATApps receive funding to turn inventions created at UNC-Chapel Hill into transformative technologies KickStart Venture Services has...
Emergo CEO Moise Khayrallah cultivates successful pharma and biotech startups and creates opportunities for other promising entrepreneurs The scratchiness in...
Clinical Sensors, a development-stage biotechnology company based in Research Triangle Park, is developing sensors that can detect and diagnose life-threatening...